Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

Mouse studies suggest fresh approach to fertility preservation

01 October 2012

By Emma Stoye

Appeared in BioNews 675

Two proteins that kick-start the destruction of damaged mouse eggs have been discovered by scientists. The findings may go on to have applications in fertility preservation for female cancer patients who receive aggressive treatment; both radiotherapy and chemotherapy can cause temporary or permanent infertility.

The study, published in the journal Molecular Cell, focused on primordial follicle oocytes - essentially eggs in an immature form which will mature into all the eggs a woman will produce in her lifetime.

When eggs are exposed to radiation or certain chemicals, the resulting damage triggers a process called apoptosis that causes the eggs to self destruct. This is how the body removes potentially dangerous, abnormal cells, but it has unwanted consequences for many women receiving cancer treatment as it can leave them infertile.

The molecular drivers behind oocyte apoptosis are relatively poorly understood, but in their study, Australian researchers discovered two proteins that play a vital role in mice: PUMA and NOXA.

When exposed to radiation, the healthy mice in the study lost all their eggs within 15 days. But when mice that had been genetically engineered not to produce PUMA were exposed to the radiation, 15 percent of their eggs survived. Survival further increased to over 50 percent in mice producing neither PUMA or NOXA.

Dr Clare Scott, at the Walter and Eliza Hall Institute of Medical Research in Victoria, Australia, the lead author of the study, told New Scientist: 'If you can prevent PUMA and NOXA from killing them, the eggs have a chance to repair their own DNA'. The mice in the experiment went on to produce healthy, fertile offspring.

Should PUMA and NOXA be as important in humans, there could be important clinical applications. A drug which blocks the activity of PUMA could potentially be used to prevent fertility loss in female cancer patients.

Another possible use would be to offset the negative effects of early menopause, such as osteoporosis and heart disease, which are currently treated with hormone replacement therapy.

'We know that the timing of menopause is influenced by how many egg cells a female has', said Professor Jock Findlay, head of the Female Reproductive Biology Group at Prince Henry's Institute, in Melbourne, who was also involved in the study. 'Interventions that slow the loss of egg cells from the ovaries could delay premature menopause, prolonging female fertility'.

However, as any drugs that effectively target PUMA or NOXA are yet to be developed such treatments would likely be decades away.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

14 April 2014 - by Cait McDonagh 
A Crohn's disease patient is challenging a decision to refuse her funding for her eggs to be cryopreserved before she undergoes a bone marrow transplant and chemotherapy...
03 December 2012 - by Dr Lucy Spain 
A former cancer patient has become the first woman in Australia to become pregnant following the pioneering procedure of ovarian tissue transplantation...

11 June 2012 - by Valerie Peddie 
Major professional bodies support the concept of providing every patient of reproductive age with accurate information about the potential risk of impaired fertility after treatment for cancer. In reality, the immediate emphasis is often on treatment, with little time available to discuss options for fertility preservation...
06 June 2011 - by Dr Charlotte Maden 
British scientists have grown mature eggs from undeveloped ones in the laboratory and are currently seeking permission to fertilise them. The new research gives hope to young girls undergoing treatment for cancer that may leave them infertile...
10 July 2008 - by Dr Charlotte Maden 
A group of German researchers has reported a new technique that will increase the chances of preserving fertility in women having treatment for cancer. The findings, presented at the annual meeting of the European Society of Human Reproduction and Embryology in Barcelona, offer new hope to female...
02 December 2002 - by BioNews 
Two new research studies have been published in the journal Human Reproduction which 'bring new hope of preserving fertility for boys who face sterility after cancer treatment'. In the first study, a Japanese team report that they have enabled mice to be born from frozen immature testicular tissue taken from...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation